Document is current
Any future updates will be listed below
-
Authors
Chen, Hsiang-Pei
Ngo, Thi Kim Ngan
Mao, Bin-Hsu
Jang, Hwanseok
Shin, Seung-Cheol
Kamm, Roger
Chung, Seok
Tu, Ting-Yuan
-
Funding
Funding for this research was provided by:
National Cheng Kung University
- License Information
-
More Information
Article History
Received: 22 September 2025
Revised: 3 December 2025
Accepted: 7 January 2026
First Online: 16 February 2026
Declarations
:
: RDK is a co-founder of AIM Biotch, a company that markets microfluidic technologies and receives research support from Amgen, AbbVie, Boehringer-Ingelheim, Daiichi-Sakyo, Novartis, and Takeda. None of these activities is related to the content of this article. The other authors declare no competing interests.
